Original Article from The New England Journal of Medicine — First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer http://www.nejm.org/doi/full/10.1056/NEJMoa1408440
Background Standard therapy for newly diagnosed glioblastoma is radiotherapy plus temozolomide. In this phase 3 study, we evaluated the effect of the addition of ... http://www.nejm.org/doi/full/10.1056/NEJMoa1308345